Edarbi (Arbor Pharmaceuticals)


Welcome to the PulseAid listing for the Edarbi drug offered from Arbor Pharmaceuticals. This Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Arbor Pharmaceuticals
NON-PROPRIETARY NAME: Azilsartan kamedoxomil
SUBSTANCE NAME: AZILSARTAN KAMEDOXOMIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-02-01
END MARKETING DATE: 0000-00-00


Edarbi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEdarbi from Arbor Pharmaceuticals
LABELER NAME: Arbor Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/1)
START MARKETING DATE: 2013-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60631-040_8f4a2c09-d658-47df-b01a-cc049b206fa6
PRODUCT NDC: 60631-040
APPLICATION NUMBER: NDA200796

Other AZILSARTAN KAMEDOXOMIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Arbor PharmaceuticalsEdarbi
Takeda Pharmaceuticals America, Inc.edarbi